UN Secretary-General, António Guterres says the world was far from achieving equitable distribution of COVID-19 vaccines, describing it as a tragedy that must be avoided at all costs.
António Guterres said this on Friday at an online Global Solutions Summit during a conversation on fair access to lifesaving treatments.
“It is absolutely essential to double the production of vaccines, and there are different mechanisms that are needed for that…but we must absolutely have an equitable distribution, and we are far from having it.
“We have seen vaccine nationalism, hoarding of vaccines, many countries buying three or four times the volume of their population.
“And on the other hand, we see enormous difficulty in supplying vaccines to the Global South. And this is a tragedy that we need to avoid at all cost,” he said.
Earlier this week, the head of the World Health Organisation (WHO) described the ongoing vaccine crisis as “a scandalous inequity”. When asked his opinion about the situation, the Secretary-General responded, “it is exactly that.”
The secretary-general highlighted the risk inequity poses in the face of a virus that spreads and mutates, noting that this was a race against time.
At the recent G20 Health Summit, vaccine producers committed to deliver one billion doses to poorer countries. While welcoming the development, the Secretary-General said it was far from enough.
Guterres stressed the need to fully fund and supply the global vaccine equity initiative, COVAX.
He noted that one of its main manufacturers, the Serum Institute of India, has had to cut back supply due to the surge in cases in the country, while deliveries from other contractors have been later than expected.
The UN Chief urged countries to channel their excess vaccines through COVAX, instead of a geo-strategic competition with several powerful countries giving vaccines to their friends, or trying to compete with each other to see who gains more influence, thanks to the vaccines.
The secretary-general also reiterated his proposal for a G20-led Task Force that would work with pharmaceutical companies and other stakeholders, to provide vaccines for all people, everywhere. (NAN)